WLS (Weight Loss Surgery) Sleeve Surgery refers to sleeve gastrectomy, a popular bariatric procedure. It is effective for individuals who need to lose a significant amount of weight but prefer a less invasive option than gastric bypass. The surgery reduces the size of the stomach and promotes weight loss by restricting food intake.

The "fat jab," also known as Saxenda or liraglutide, is an injectable weight-loss drug that has been approved for use on the NHS in the UK for individuals struggling with obesity. It is intended for use in conjunction with a reduced-calorie diet and increased physical activity. The medication helps control appetite, leading to weight loss. It is typically prescribed to those with a BMI over 30 or individuals with weight-related health problems.

The lap band and sleeve gastrectomy are two different bariatric surgeries. The lap band is adjustable and reversible, involving the placement of a band around the upper stomach. The sleeve, on the other hand, is permanent and involves the removal of part of the stomach. Sleeve gastrectomy tends to offer more substantial long-term weight loss, but the lap band has fewer immediate risks.

Abdominal cancer refers to any malignant tumor in the abdomen, including stomach, liver, pancreatic, or colon cancer. Symptoms vary but may include unexplained weight loss, abdominal pain, and changes in bowel habits. Early detection is crucial for successful treatment, which may involve surgery, chemotherapy, or radiation.

The "Skinny Pen" refers to a weight-loss medication called liraglutide (brand name Saxenda) that is administered through a daily injection. It works by mimicking a hormone that regulates appetite, helping patients feel fuller for longer. This treatment is often used for individuals who struggle with obesity but are not candidates for surgery or who need additional help in managing their weight post-bariatric surgery. The drug is available by prescription and is used in conjunction with diet and exercise.

A total gastrectomy is a surgical procedure where the entire stomach is removed, usually due to stomach cancer or severe damage. The esophagus is then directly connected to the small intestine. This life-altering surgery requires patients to follow strict dietary guidelines, including smaller, more frequent meals, and take supplements to ensure proper nutrition.

Gastric RNY, or Roux-en-Y gastric bypass, remains one of the most effective surgical options for treating obesity. By reducing the size of the stomach and bypassing a portion of the intestines, patients experience a significant reduction in hunger and an inability to eat large meals. Gastric RNY can lead to rapid weight loss and improvement or resolution of obesity-related conditions such as type 2 diabetes, sleep apnea, and hypertension.

The pre-surgical diet is designed to reduce the size of the liver and optimize the patient’s health before bariatric surgery. Typically high in protein and low in carbohydrates, it often involves consuming liquid protein shakes and limited solid foods for 1 to 2 weeks before surgery. This diet reduces surgical risks and prepares the body for the changes it will undergo post-surgery.

Similar to slimming injections, fat loss injections such as lipotropic injections are designed to enhance metabolism and fat-burning processes. These injections often contain a combination of nutrients like B12, amino acids, and other compounds that may help with fat breakdown, but their efficacy varies.

Roux-en-Y gastric bypass is one of the most common bariatric surgeries, combining restrictive and malabsorptive techniques. It helps patients lose weight by creating a small stomach pouch and bypassing part of the small intestine, reducing calorie absorption. It’s highly effective but requires lifelong dietary changes and nutritional supplementation.